{"nct_id":"NCT00730847","title":"A Study to Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards.","status":"TERMINATED","status_verified_date":"2019-10","start_date":"2008-09-17","start_date_type":"ACTUAL","primary_completion_date":"2012-01-16","primary_completion_date_type":"ACTUAL","completion_date":"2012-01-16","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["GSK"]}